PharmaSGP Holding SE
XETRA:PSG

Watchlist Manager
PharmaSGP Holding SE Logo
PharmaSGP Holding SE
XETRA:PSG
Watchlist
Price: 23.6 EUR -6.35% Market Closed
Market Cap: 283m EUR
Have any thoughts about
PharmaSGP Holding SE?
Write Note

PharmaSGP Holding SE
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

PharmaSGP Holding SE
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
PharmaSGP Holding SE
XETRA:PSG
Other Long-Term Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ATAI Life Sciences NV
NASDAQ:ATAI
Other Long-Term Assets
$2.7m
CAGR 3-Years
13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Other Long-Term Assets
€5.9B
CAGR 3-Years
8%
CAGR 5-Years
4%
CAGR 10-Years
11%
Merck KGaA
XETRA:MRK
Other Long-Term Assets
€1.7B
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
6%
MPH Health Care AG
XETRA:93M1
Other Long-Term Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Other Long-Term Assets
-€2k
CAGR 3-Years
N/A
CAGR 5-Years
-15%
CAGR 10-Years
N/A
No Stocks Found

PharmaSGP Holding SE
Glance View

Market Cap
283m EUR
Industry
Pharmaceuticals

PharmaSGP Holding SE engages in the sale and marketing of non-prescription drugs, chemical-free over-the-counter painkillers, as well as herbal medicines. The company is headquartered in Graefelfing, Bayern. The company went IPO on 2020-06-19. The firm produces and develops non-chemical and over-the-counter drugs and other healthcare products.

PSG Intrinsic Value
45.28 EUR
Undervaluation 48%
Intrinsic Value
Price

See Also

Back to Top